1. Home
  2. TOUR vs XLO Comparison

TOUR vs XLO Comparison

Compare TOUR & XLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

TOUR

Tuniu Corporation

N/A

Current Price

$4.99

Market Cap

55.2M

ML Signal

N/A

XLO

Xilio Therapeutics Inc.

N/A

Current Price

$9.14

Market Cap

56.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TOUR
XLO
Founded
2006
2016
Country
China
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.2M
56.9M
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
TOUR
XLO
Price
$4.99
$9.14
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
4.4K
★ 7.6K
Earning Date
08-25-2026
11-12-2026
Dividend Yield
★ 24.13%
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $43,766,000.00
Revenue This Year
$5.00
N/A
Revenue Next Year
$3.00
N/A
P/E Ratio
$87.34
★ N/A
Revenue Growth
N/A
★ 589.88
52 Week Low
$0.56
$0.46
52 Week High
$7.79
$9.90

Technical Indicators

Market Signals
Indicator
TOUR
XLO
Relative Strength Index (RSI) 45.37 47.69
Support Level $4.93 $8.63
Resistance Level $5.31 $9.15
Average True Range (ATR) 0.11 0.24
MACD -0.01 0.00
Stochastic Oscillator 0.00 5.41

Price Performance

Historical Comparison
TOUR
XLO

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. The company offers a large selection of packaged tours, including organized tours and self-guided tours, and travel-related services for leisure travellers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

Share on Social Networks: